Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jutta Engel

Showing results (21-30 of 156) with videos related to

Pageof 16
Sort By:
European Journal of Cancer (Oxford, England : 1990)|May 1, 2009
CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancerDavid Horst, Lydia Kriegl, Jutta Engel, et al.
Cancer Investigation|July 24, 2009
Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancerDavid Horst, Lydia Kriegl, Jutta Engel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2011
Toward the prognostic significance and therapeutic potential of HER3 receptor tyrosine kinase in human colon cancerAbdelhamid Beji, David Horst, Jutta Engel, et al.
Breast (Edinburgh, Scotland)|August 16, 2019
Lymph node infiltration, parallel metastasis and treatment success in breast cancerJutta Engel, Wilko Weichert, Andreas Jung, et al.
Virchows Archiv : an International Journal of Pathology|April 21, 2018
The prognostic impact of CDX2 correlates with the underlying mismatch repair status and BRAF mutational status but not with distant metastasis in colorectal cancerJens Neumann, Volker Heinemann, Jutta Engel, et al.
Studies in Health Technology and Informatics|August 28, 2014
Matching study to registry data: maintaining data privacy in a study on family based colorectal cancerDaniel Nasseh, Jutta Engel, Ulrich Mansmann, et al.
Diseases of the Colon and Rectum|August 9, 2003
Doctor-patient communication: results of a four-year prospective study in rectal cancer patientsJacqueline Kerr, Jutta Engel, Anne Schlesinger-Raab, et al.
Breast Cancer Research and Treatment|June 5, 2003
Axilla surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patientsJutta Engel, Jacqueline Kerr, Anne Schlesinger-Raab, et al.
Journal of Cancer Research and Clinical Oncology|December 20, 2022
Breast cancer: emerging principles of metastasis, adjuvant and neoadjuvant treatment from cancer registry dataJutta Engel, Renate Eckel, Kathrin Halfter, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2008
Metastatic renal cell carcinoma: results of a population-based study with 25 years follow-upAnne Schlesinger-Raab, Uwe Treiber, Dirk Zaak, et al.
Pageof 16

Showing results (21-30 of 156) with videos related to

Sort By:
Pageof 16
European Journal of Cancer (Oxford, England : 1990)|May 1, 2009
CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancerDavid Horst, Lydia Kriegl, Jutta Engel, et al.
Cancer Investigation|July 24, 2009
Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancerDavid Horst, Lydia Kriegl, Jutta Engel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2011
Toward the prognostic significance and therapeutic potential of HER3 receptor tyrosine kinase in human colon cancerAbdelhamid Beji, David Horst, Jutta Engel, et al.
Breast (Edinburgh, Scotland)|August 16, 2019
Lymph node infiltration, parallel metastasis and treatment success in breast cancerJutta Engel, Wilko Weichert, Andreas Jung, et al.
Virchows Archiv : an International Journal of Pathology|April 21, 2018
The prognostic impact of CDX2 correlates with the underlying mismatch repair status and BRAF mutational status but not with distant metastasis in colorectal cancerJens Neumann, Volker Heinemann, Jutta Engel, et al.
Studies in Health Technology and Informatics|August 28, 2014
Matching study to registry data: maintaining data privacy in a study on family based colorectal cancerDaniel Nasseh, Jutta Engel, Ulrich Mansmann, et al.
Diseases of the Colon and Rectum|August 9, 2003
Doctor-patient communication: results of a four-year prospective study in rectal cancer patientsJacqueline Kerr, Jutta Engel, Anne Schlesinger-Raab, et al.
Breast Cancer Research and Treatment|June 5, 2003
Axilla surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patientsJutta Engel, Jacqueline Kerr, Anne Schlesinger-Raab, et al.
Journal of Cancer Research and Clinical Oncology|December 20, 2022
Breast cancer: emerging principles of metastasis, adjuvant and neoadjuvant treatment from cancer registry dataJutta Engel, Renate Eckel, Kathrin Halfter, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2008
Metastatic renal cell carcinoma: results of a population-based study with 25 years follow-upAnne Schlesinger-Raab, Uwe Treiber, Dirk Zaak, et al.
Pageof 16